Drug Shortage Report for CETROTIDE
| Report ID | 161102 |
| Drug Identification Number | 02247766 |
| Brand name | CETROTIDE |
| Common or Proper name | Cetrorelix for Injection |
| Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA |
| Market Status | MARKETED |
| Active Ingredient(s) | CETRORELIX |
| Strength(s) | 0.25MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | Vial (2mL) |
| ATC code | H01CC |
| ATC description | HYPOTHALAMIC HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-23 |
| Estimated end date | 2022-08-15 |
| Actual end date | 2022-08-16 |
| Shortage status | Resolved |
| Updated date | 2022-08-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2695 NORTH SHERIDAN WAY, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5K 2N6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-08-17 | French | Compare |
| v7 | 2022-08-17 | English | Compare |
| v6 | 2022-06-28 | French | Compare |
| v5 | 2022-06-28 | English | Compare |
| v4 | 2022-05-24 | English | Compare |
| v3 | 2022-05-21 | French | Compare |
| v2 | 2022-05-21 | French | Compare |
| v1 | 2022-05-21 | English | Compare |
Showing 1 to 8 of 8